CTRV Stock Soars 40% as FDA Issues Positive Response for CRV431
CTRV stock is one of the biggest biotech stocks after ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) gets a positive response from the FDA to its pre-IND meeting for developing CRV431 in NASH. Big Announcement New Jersey-based biopharmaceutical ... [Read]
ContraVir Pharmaceuticals Announces Reverse Stock Split
New Jersey-based biotechnology company ContraVir Pharmaceuticals (NASDAQ:CTRV) announced on Thursday that it will be having a reverse split of its common stock. A reverse stock split is meant to help a company to reduce “the ... [Read]